Cardiovascular Collaboration
Cardiovascular Diseases
DiscoveryActive
Key Facts
About Unnatural Products
Unnatural Products is a private, pre-clinical stage biotech leveraging a proprietary, integrated platform for the design and optimization of synthetic macrocyclic peptides. The company's technology, born out of academic research from the Lokey Lab, combines digital and physical lab tools in an iterative loop to rapidly generate drug-like candidates for traditionally intractable targets. UNP is advancing a targeted internal portfolio while also engaging in strategic partnerships with pharmaceutical leaders to apply its modality to high-value biology in oncology, immunology, cardiovascular, and rare diseases.
View full company profileTherapeutic Areas
Other Cardiovascular Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Anti-platelet | Dawah Pharmaceuticals | Development |
| Autonomic Therapy Initiative (ATI) | BIOS Health | Pre-clinical |
| Cardiology Diagnostics Program | Aptus Biosciences | Discovery |
| SBX 2000 | Stramsen Biotech | Early-stage Clinical |
| Not specified on provided pages | Cadila Pharmaceuticals | Commercial (World's First Claim) |
| Cardiovascular Biomarkers R&D | Firalis | Development |
| EPS222 | Eusol Biotech | Preclinical |